Search - tctmd.com

Displaying 201 - 220 of 4671

Sort: Relevancy | Date

May 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

May 20, 2025

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

May 16, 2025

Tirzepatide Tops Semaglutide for Weight Loss SURMOUNT-5

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

News Daily News

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

May 08, 2025

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients

News Conference News SCAI 2025

BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients

May 07, 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

News Conference News HRS 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

May 05, 2025

Pain in the Neck? Operators Seek Solutions to Lead’s Weighty Toll

News Conference News SCAI 2025

Pain in the Neck? Operators Seek Solutions to Lead’s Weighty Toll

May 05, 2025

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

April 24, 2025

HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation

News Daily News

HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation

April 24, 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

April 23, 2025

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

April 17, 2025

Cardiotoxicity Rare With Common GI Chemotherapy

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

April 15, 2025

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

News Daily News

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

April 14, 2025

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

April 14, 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

April 10, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.